Our Commitment to Safety and Wellbeing

At RGCC, we are deeply committed to protecting the health, safety, and wellbeing of our employees, partners, and the wider community.

You can view our policies below.

Occupational Health and Safety Policy

Which tests support follow-ups and patient monitoring?
Oncocount, Oncotrace or Oncotrail tests are useful in the follow up and monitoring of specific types of tumors.
What else does RGCC do?
In addition to pioneering personalized genetic testing for cancer, RGCC is deeply engaged in pharmaceutical research and development, operating from our cutting-edge facilities in Europe. Our esteemed scientists regularly publish peer-reviewed research, earning respect on a global scale.
Can brain tumors also be tested with a blood sample?
No, the blood-brain barrier prevents tumor cells from entering the bloodstream. Consequently, we cannot obtain or isolate any tumor cells from a blood sample. However, in such cases, cerebrospinal fluid can be used.
Is it possible to measure circulating tumour cells (CTC) in patients with lymphoma or leukaemia?
Certainly, patients with lymphoma or leukemia can utilize an RGCC test to measure the number of circulating tumor cells (CTC) they have.
What types of tests does RGCC offer?
RGCC provides a comprehensive range of tests designed to detect, analyze, and screen cancer cells. Our current portfolio includes tests capable of identifying potential early signs of cancer, monitoring diagnosed cancers, and offering personalized guidance on the most effective combinations of cancer treatments and therapies, including complementary approaches.